CD86 and neoplasm: In accordance with these results, flow cytometry analysis displayed a similar expression pattern in primary implanted and regrown tumors, indicating a shift toward CD86 marker expression shortly after tumor resection and then another shift towards high expression of both CD206 and CD86 in fully regrown tumors (Figure 5).